Achilles Therapeutics PLC (ACHL)
0.8037
+0.02
(+3.04%)
USD |
NASDAQ |
May 03, 16:00
0.8245
+0.02
(+2.59%)
After-Hours: 20:00
Achilles Therapeutics Price to Book Value: 0.2343 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 0.2343 |
May 02, 2024 | 0.2273 |
May 01, 2024 | 0.2279 |
April 30, 2024 | 0.2186 |
April 29, 2024 | 0.2215 |
April 26, 2024 | 0.2215 |
April 25, 2024 | 0.2257 |
April 24, 2024 | 0.2285 |
April 23, 2024 | 0.2277 |
April 22, 2024 | 0.2303 |
April 19, 2024 | 0.2282 |
April 18, 2024 | 0.2332 |
April 17, 2024 | 0.2374 |
April 16, 2024 | 0.2338 |
April 15, 2024 | 0.2398 |
April 12, 2024 | 0.2477 |
April 11, 2024 | 0.2477 |
April 10, 2024 | 0.2389 |
April 09, 2024 | 0.2434 |
April 08, 2024 | 0.2421 |
April 05, 2024 | 0.2451 |
April 04, 2024 | 0.2632 |
April 03, 2024 | 0.3498 |
April 02, 2024 | 0.3468 |
April 01, 2024 | 0.3643 |
Date | Value |
---|---|
March 28, 2024 | 0.3643 |
March 27, 2024 | 0.3468 |
March 26, 2024 | 0.3614 |
March 25, 2024 | 0.3585 |
March 22, 2024 | 0.3731 |
March 21, 2024 | 0.3702 |
March 20, 2024 | 0.376 |
March 19, 2024 | 0.3468 |
March 18, 2024 | 0.3206 |
March 15, 2024 | 0.3206 |
March 14, 2024 | 0.3235 |
March 13, 2024 | 0.3556 |
March 12, 2024 | 0.3585 |
March 11, 2024 | 0.3585 |
March 08, 2024 | 0.3585 |
March 07, 2024 | 0.3556 |
March 06, 2024 | 0.3614 |
March 05, 2024 | 0.3789 |
March 04, 2024 | 0.4314 |
March 01, 2024 | 0.3964 |
February 29, 2024 | 0.3809 |
February 28, 2024 | 0.453 |
February 27, 2024 | 0.43 |
February 26, 2024 | 0.3925 |
February 23, 2024 | 0.3925 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1596
Minimum
Dec 21 2022
4.055
Maximum
Apr 06 2021
0.6286
Average
0.3793
Median
Apr 25 2022
Price to Book Value Benchmarks
Barinthus Biotherapeutics PLC | 0.4543 |
TC BioPharm (Holdings) PLC | 1.364 |
Adaptimmune Therapeutics PLC | 7.434 |
Biodexa Pharmaceuticals Plc | 0.8683 |
Verona Pharma PLC | 5.087 |
Price to Book Value Related Metrics
Price | 0.8037 |
Earnings Yield | -216.5% |
Market Cap | 33.35M |